You are here

HASTANE KAYNAKLI (Nozokomiyal) MANTAR İNFEKSİYONLARININ EPİDEMİYOLOJİSİ

Journal Name:

Publication Year:

Keywords (Original Language):

Abstract (2. Language): 
Nosocomial fungal infections have became important causes of morbidity and mortality over the last ten years. Immunocompromised patients are at a high risk of hospital acquired fungal infections, specially candidemia. Epidemiology of nosocomial fungal infections concerning on frequently isolated causative agents and major risk factors have been reviewed in this paper.
Abstract (Original Language): 
Hastanede kazanılan (nozokomiyal) infeksiyonlar özellikle son on yıldır önemli bir morbidite ve mortalite sebebi olmuştur. Bağışıklık yetmezlikli hastalar hastane kaynaklı mantar infeksiyonu, özellikle kandidemi açısından yüksek risk altındad ırlar. Bu derlemede, sıklıkla ayrıldığı bildirilen hastane kaynaklı mantarlar ve başlıca risk faktörleri üzerinde durularak hastanede kazanılan mantar infeksiyonlar ının epidemiyolojisi gözden geçirilmiştir.

REFERENCES

References: 

1. Richardson MD, Warnock DW. Fungal Infection.
Diagnosis and Management. 2nd ed. London:
Blackwell Science; 1997.
2. Jarvis WR. Investigating Endemic and Epidemic
Nosocomial Infections. Hospital Infections
’da. Bennett JV, Brachman PS Eds. Philadelphia,
Lippincott-Raven, 1998; 3-16.
3. Baron EJ, Peterson LR, Finegold SM. Hospital
Epidemiology. Bailey and Scott’s Diagnostic
Microbiology’de. 9th ed. St Louis: Mosby-Year
Book, Inc; 1994; 41.
4. Lunel V. Nosocomial fungal infections: candidemia.
Diagn Microbiol Infect Dis 1999; 34: 213-
220.
5. Branchini ML, Pfaller MA, Rhine-Chalberg J,
Frempong T, Isenberg HD. Genotipic variation
and slime production among blood and catheter
isolates of Candida parapsilosis. J Clin Microbiol
1994; 32: 452-456.
6. Fridkin SK. Epidemiology of nosocomial fungal
infections. Clin Microbial Rev 1996; 9: 499-511.
7. van Saene HKF, Damjanovic V, Pizer B, Petros
AJ. Fungal infections in ICU. J Hospital Infect
1999; 41: 337-340.
8. Sobel JD, Kauffman CA, McKinsey D, Zervos
M, Vazquez JA, Karchmer AW, Lee J, Thomas
C, Panzer H, Dismukes and the National Institute
of Allergy and Infectious Diseases (NIAID)
Mycosis Study Group. Candiduria: a randomized,
double-blind study of treatment with fluconazole
and placebo. Clin Infect Dis 2000; 30:
19-24.
9. Kauffman CA, Vazquez JA, Sobel JD, Gallis
HA, McKinsey DS, Karchmer AW, Sugar AM,
Sharkey PK, Wise GJ, Mangi R, Mosher A, Lee
JY, Dismukes WE and the National Institute of
Allergy and Infectious Diseases (NIAID) Mycosis
Study Group. Prospective multicenter surveillance
study of funguria in hospitalized patients.
Clin Infect Dis 2000; 30: 14-18.
10. Hoşoğlu S. Nozokomiyal hematojen kandidoz.
1. Ulusal Mantar Hastalõklarõ ve Klinik Mikoloji
Kongresi (4-6 Mayıs 1999, İzmir), Tutanaklar.
Türk Mikrobiyoloji Cem Y no.36, 1999; 157-
165.
11. Pittet D, Harbarth J. The intensive care unit
infections. In: Bennet JV, Brachman PS (eds).
Hospital Infections. 4üncü baskõ. Philadelphia:
Lippincott, 1998; 384.
12. Pfaller M, Wenzel R. Impact of the changing
epidemiology of fungal infections in the 1990’s.
Eur J Clin Microbiol Dis 1992; 11: 287-291.
13. Jarvis WR. Epidemiology of nosocomial fungal
infections, with emphasis on Candida species.
Clin Infect Dis 1995; 20: 1526-1530.
14. Glöckner A, Wiersbitzky M, Schulz K, Bernhardt
H. Risk factors for systemic fungal infection
in patients of non-surgical ICU. Abstracts
of 5th Congress of the European Confederation
of Medical Mycology (3-6 June 1999, Dresden,
Germany). Mycoses 1999; 42: 177.
15. Mozingo DW, McManus AT, Pruitt BA. Infections
of Burn Wounds. In: Bennett JV, Brachman
PS (Eds). Hospital Infections. Philadelphia:
Lippincott- Raven; 1998: 587-597.
16. Hamal P, Raclavsky V, Hrüokova O, Pichova I,
Zalenkova J, Pavlicek J, Hejnar P. Characterisation
of nosocomial Candida strains: resistance
to antifungal agents; proteinase production,
RAPD typing. Abstracts of 5th Congress of
the European Confederation of Medical Mycology
(3-6 June 1999, Dresden, Germany). Mycoses
1999; 42: 180-181.
17. Bruun B, Westh H, Stenderup J. Fungemia: an
increasing problem in a Danish university hospital
1989 to 1994. J Clin Microbiol Infect 1995;
1: 124-126.
18. Back-Sague C, Jarvis WR. Secular trends in
the epidemiology of nosocomial fungal infections
in the United States, 1980-1990 and National
Nosocomial Infectious Surveillance System.
J Infect Dis 1993; 167: 1247-1251.
19. Hawser SP, Baillie GS, Douglas J. Production
of extracellular matrix by Candida albicans
biofilms. J Med Microbiol 1998; 47: 253-256.
20. Nikawa H, Nishimura H, Hamada T, Yamashiro
H, Samaranayake LP. Effects of modified
pellicles on Candida biofilm formation on
acrylic surfaces. Mycoses 1999; 42: 37-40.
21. Edmond MB, Wallace SE, McClish DK, Pfaller
MA, Jones RN, Wenzel RP. Nosocomial bloodstream
infections in United States Hospitals: a
three-year analysis. Clin Infect Dis 1999; 29:
239-244.
22. Rangel-Frausto S, Wiblin T, Blumberg HM,
Siman L, Patterson J, Rinaldi M, Pfaller M,
Edwards JE, Jarvis W, Dawson J. National epidemiology
of mycoses survey (NEMIS): variations
in rates of bloodstream infections due to
Candida species in seven surgical intensive
care units and six neonatal intensive care
units. Clin Infect Dis 1999; 29: 253-258.
23. Launay O, Lortholary O, Bourges-Michel C,
Jarrousse B, Bentata M, Guillevin L. Candidemia:
A nosocomial complication in adults with
late-stage AIDS. Clin Infect Dis 1998; 26: 1134-
1141.
24. Akova M. Nötropenik hastalarda infeksiyonlar
ve korunma. Aktüel Tıp Derg 1996; 6: 485-490.
25. Ener B. Hastane İnfeksiyonu Etkeni Olarak
Mantarlar. Ş. Ustaçelebi (ed) Temel ve Klinik
Mikrobiyoloji. Ankara, 1999:1123-1128.
26. Tünger Ö, Özbakkaloğlu B, Dinç G, Sürücüoğlu
S, Sivrel Arısoy A, Baykal A. Celal Bayar Üniversitesi
Hastanesi’nde 1998 yılı hastane
infeksiyonları sürveyans sonuçları. İnfeksiyon
Derg 1999; 3: 359-364.
27. Stamm WE. Urinary Tract Infections. Hospital
Infections’da. Bennett JV, Brachman PS Eds.
Philadelphia, Lippincott-Raven, 1998; 477-487.
28. Yücel A, Kantarcıoğlu AS. Candida’ların patojenlik
belirtgenleri. Cerr Tıp Derg 2000; 31:
172-186.
29. Taşova Y, Saltoğlu N, Yaman A, Yılmaz G,
Dündar İH. Çukurova Üniversitesi Tıp Fakültesi
Hastanesi’nde nozokomiyal idrar yolu
infeksiyonları. İnfeksiyon Derg 1999; 13: 249-
254.
30. Bibashi E, Sofianou D, Kokolina E, Kati C,
Kriklidou P, Papadimitriou M. Fungal peritonitis
during continuous ambulatory peritoneal
dialysis: a report of 32 cases. Abstracts of 5th
Congress of the European Confederation of
Medical Mycology (3-6 June 1999, Dresden,
Germany). Mycoses 1999; 42: 168.
31. Siegel JD. The Newborn Nursery. Bennett JV,
Brachman PS (Eds). Hospital Infections’da.
Philadelphia: Lippincott- Raven; 1998; 403-420.
32. Yücel A. Tıp mikolojisinin dünü bugünü. I.
Ulusal Mantar Hastalıkları ve Klinik Mikoloji
Kongresi (4-6 Mayõs 1999, İzmir), Tutanaklar.
Türk Mikrobiyoloji Cem Yay. No.36, 1999; 3-16.
33. Ener B, Sınırtaş M, Akalın H, Hacımustafaoğlu
M, Özakın C, Gedikoğlu S, Töre O, Gökırmak
F. Nozokomiyal kandidemi etkenlerinin
retrospektif analizi. İnfeksiyon Derg 1998; 12:
85-88.
34. Rhame FS. The Inanimate Environment. In:
Bennett JV, Brachman PS (Eds). Hospital Infections.
Philadelphia: Lippincott- Raven; 1998;
299-324.
35. Rippon JW. Medical mycology. Third edition.
Philadelphia, WB Saunders Company, 1988;
325-352.
36. Maki DG, Mermel LA. Infections due to Infusion
Therapy. In: Bennett JV, Brachman PS
(Eds). Hospital Infections. Philadelphia: Lippincott-
Raven; 1998; 689-724.
37. Walsh TJ, Dixon DM. Nosocomial aspergillosis:
environmental microbiology, hospital epidemiology,
diagnosis and treatment. Eur J Epidemiol
1989; 5: 131-142.
38. Kerkmann ML, Hirsch T, Bürkner K, Hering
M, Jatzwauk L. Indoor climate effects in dwellings
after installation of insulating windows
and central heating systems and their influence
on indoor mould infestation. Abstracts of
5th Congress of the European Confederation of
Medical Mycology (3-6 June 1999, Dresden,
Germany). Mycoses 1999; 42: 185-186.
39. Fitzpatrick F, Prout S, Gilleece A, Fenelon LE,
Murphy OM. Nosocomial aspergillosis during
building work-a multidisciplinary approach. J
Hospital Infect 1999; 2: 170-171.
40. Weems JJ, Andremont A, Davis BJ, Tancrede
CH, Guiguet M, Padhye AA, Squinazi F, Martone
WJ. Psudoepidemic of aspergillosis after
development of pulmonary infiltration in a
group of bone marrow transplant patients. J
Clin Microbiol 1987; 25: 1459-1462.
41. Macura AB. The occurrence of fungi in the environment
and in the inmates of a social welfare
home. Abstracts of 5th Congress of the
European Confederation of Medical Mycology
(3-6 June 1999, Dresden, Germany). Mycoses
1999; 42: 191-192.
42. Scheld WM, Farr BM. Central Nervous System
Infections. In: Bennett JV, Brachman PS (Eds).
Hospital Infections. Philadelphia: Lippincott-
Raven; 1998; 563-569.
43. Hagensee ME, Bauwens JE, Kjos B, Bowden
RA. Brain abscess following marrow transplantation:
experience at the Fred Hutchinson Cancer
Research Center, 1984-1992. Clin Infect Dis
1994; 19: 402-408.
44. Karcı B. Mantar sinüzitleri. I. Ulusal Mantar
Hastalıkları ve Klinik Mikoloji Kongresi (4-6
Mayıs 1999, İzmir), Tutanaklar 1999; 37-41.
45. Mutlu G. Aspergillus ve aspergilloz. I.Ulusal
Mantar Hastalıkları ve Klinik Mikoloji Kongresi
(4-6 Mayıs 1999, İzmir), Tutanaklar 1999;
17-36.
46. Wurtz RM, Knospe WN. Malassezia furfur in a
patient without the usual risk factors. Ann Intern
Med 1988; 167: 432-433.
47. Yücel A. Kriptokok ve Diğer Maya formundaki
mantarlar. İnfeksiyon Hastalıkları’nda. 2nci
baskı. Ed. Wilke A, Söyletir G, Doğanay M.
(Baskıda).
48. Kwon Chung KJ, Bennett JE. Medical Mycology.
Philadelphia; Lea and Febiger, 1992.
49. Gorbach SL. Antimicrobial resistance in the
1990’s. Hospital Infection Control 1997; 2: 18-
22.

Thank you for copying data from http://www.arastirmax.com